The response to OTX105 differs in tumor types encompassing mechanisms that include suppression of cell proliferation and viability, downregulation of MYC/MYCN proteins and MYC-regulated transcriptional programs, loss of stemness features and chromatin remodeling [25,27,29]. The gene discussed is MYCN; the disease is neoplasm.